-
1
-
-
0345764793
-
In vitro properties of medial vestibular neurones
-
Shimazu H, Shinoda Y, eds. Basel: Karger
-
Serafin M. In vitro properties of medial vestibular neurones. In Shimazu H, Shinoda Y, eds. Vestibular and brain stem control of eye, head and body movement. Basel: Karger; 1992. p. 111-21.
-
(1992)
Vestibular and Brain Stem Control of Eye, Head and Body Movement
, pp. 111-121
-
-
Serafin, M.1
-
2
-
-
0028285055
-
Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: A double-blind, randomized trial of three intravenous drugs
-
Barton JJ, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 1994; 35: 319-25.
-
(1994)
Ann Neurol
, vol.35
, pp. 319-325
-
-
Barton, J.J.1
Huaman, A.G.2
Sharpe, J.A.3
-
3
-
-
0026577098
-
The pathways and functions of GABA in the oculomotor system
-
Spencer RF, Wang SF, Baker R. The pathways and functions of GABA in the oculomotor system. Prog Brain Res 1992; 90: 307-31.
-
(1992)
Prog Brain Res
, vol.90
, pp. 307-331
-
-
Spencer, R.F.1
Wang, S.F.2
Baker, R.3
-
4
-
-
0024819201
-
Depression of the vestibulo-ocular and optokinetic responses by intrafloccular microinjection of GABA-A and GABA-B agonists in the rabbit
-
Van Neerven J, Pompeiano O, Collewijn H. Depression of the vestibulo-ocular and optokinetic responses by intrafloccular microinjection of GABA-A and GABA-B agonists in the rabbit. Arch Ital Biol 1989; 127: 243-63.
-
(1989)
Arch Ital Biol
, vol.127
, pp. 243-263
-
-
Van Neerven, J.1
Pompeiano, O.2
Collewijn, H.3
-
5
-
-
0023598159
-
Baclofen and velocity storage: A model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey
-
Cohen B, Helwig D, Raphan T. Baclofen and velocity storage: a model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey. J Physiol 1987; 393: 703-25.
-
(1987)
J Physiol
, vol.393
, pp. 703-725
-
-
Cohen, B.1
Helwig, D.2
Raphan, T.3
-
6
-
-
0024418870
-
Neurochemical mechanisms of motion sickness
-
Takeda N, Morita M, Hasegawa S, Kubo T, Matsunaga T. Neurochemical mechanisms of motion sickness. Am J Otolaryngol 1989; 10: 351-59.
-
(1989)
Am J Otolaryngol
, vol.10
, pp. 351-359
-
-
Takeda, N.1
Morita, M.2
Hasegawa, S.3
Kubo, T.4
Matsunaga, T.5
-
7
-
-
0018745354
-
Antimotion sickness and antiemetic drugs
-
Wood CD. Antimotion sickness and antiemetic drugs. Drugs 1979; 17: 471-9.
-
(1979)
Drugs
, vol.17
, pp. 471-479
-
-
Wood, C.D.1
-
8
-
-
0242359985
-
The management of patients with vestibular disorders
-
Barber H, Sharpe J, eds. Chicago: Year book Medical Publishing
-
Zee D. The management of patients with vestibular disorders. In Barber H, Sharpe J, eds. Vestibular disorders. Chicago: Year book Medical Publishing; 1988. p. 254-74.
-
(1988)
Vestibular Disorders
, pp. 254-274
-
-
Zee, D.1
-
9
-
-
0023093943
-
Psychotropic drug use and the risk of hip fracture
-
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363-9.
-
(1987)
N Engl J Med
, vol.316
, pp. 363-369
-
-
Ray, W.A.1
Griffin, M.R.2
Schaffner, W.3
Baugh, D.K.4
Melton, L.J.5
-
11
-
-
0029764850
-
Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine
-
Verspeelt J, De Locht P, Amery WK. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. Eur J Clin Pharmacol 1996; 51: 15-22.
-
(1996)
Eur J Clin Pharmacol
, vol.51
, pp. 15-22
-
-
Verspeelt, J.1
De Locht, P.2
Amery, W.K.3
-
12
-
-
0030055147
-
Use of nimodipine in the medical treatment of Meniere's disease: Clinical experience
-
Lassen LF, Hirsch BE, Kamerer DB. Use of nimodipine in the medical treatment of Meniere's disease: clinical experience. Am J Otol 1996; 17: 577-80.
-
(1996)
Am J Otol
, vol.17
, pp. 577-580
-
-
Lassen, L.F.1
Hirsch, B.E.2
Kamerer, D.B.3
-
13
-
-
0026956404
-
Calcium currents in solitary hair cells isolated from frog crista ampullaris
-
Prigioni I, Masetto S, Russo G, Taglietti V. Calcium currents in solitary hair cells isolated from frog crista ampullaris. J Vestib Res 1992; 2: 31-9.
-
(1992)
J Vestib Res
, vol.2
, pp. 31-39
-
-
Prigioni, I.1
Masetto, S.2
Russo, G.3
Taglietti, V.4
-
14
-
-
0025767658
-
Interaction of flunarizine with dopamine D2 and D1 receptors
-
Ambrosio C, Stefanini E. Interaction of flunarizine with dopamine D2 and D1 receptors. Eur J Pharmacol 1991; 197: 221-23.
-
(1991)
Eur J Pharmacol
, vol.197
, pp. 221-223
-
-
Ambrosio, C.1
Stefanini, E.2
-
15
-
-
0023687079
-
Differential antiepileptic effects of the organic calcium antagonists verapamil and flunarizine in neurons of organotypic neocortical explants from newborn rats
-
Bingmann D, Speckmann EJ, Baker RE, Ruijter J, de Jong BM. Differential antiepileptic effects of the organic calcium antagonists verapamil and flunarizine in neurons of organotypic neocortical explants from newborn rats. Exp Brain Res 1988; 72: 439-42.
-
(1988)
Exp Brain Res
, vol.72
, pp. 439-442
-
-
Bingmann, D.1
Speckmann, E.J.2
Baker, R.E.3
Ruijter, J.4
De Jong, B.M.5
-
16
-
-
0024834223
-
Calcium antagonists and the vestibular system: A critical review of flunarizine as an antivertigo drug
-
Rascol O, Clanet M, Montastruc JL. Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drug. Fundam Clin Pharmacol 1989; 3 (Suppl): 79s-87.
-
(1989)
Fundam Clin Pharmacol
, vol.3
, Issue.SUPPL.
-
-
Rascol, O.1
Clanet, M.2
Montastruc, J.L.3
-
17
-
-
0026610048
-
The prevalence of migraine in Meniere's disease
-
Rassekh CH, Harker LA. The prevalence of migraine in Meniere's disease. Laryngoscope 1992; 102: 135-8.
-
(1992)
Laryngoscope
, vol.102
, pp. 135-138
-
-
Rassekh, C.H.1
Harker, L.A.2
-
18
-
-
7144262400
-
Efficacy and safety of dotarizine vs. cinnarizine in the symptomatic treatment of acute balance disorders (common vertigo)
-
Perello E, Esteller E, Colls A, Magrina C, Massegur H, Lluansi J, et al. Efficacy and safety of dotarizine vs. cinnarizine in the symptomatic treatment of acute balance disorders (common vertigo). An Otorrinolaringol Ibero Am 1998; 25: 291-310.
-
(1998)
An Otorrinolaringol Ibero Am
, vol.25
, pp. 291-310
-
-
Perello, E.1
Esteller, E.2
Colls, A.3
Magrina, C.4
Massegur, H.5
Lluansi, J.6
-
19
-
-
0028106503
-
Phenytoin for motion sickness: Clinical evaluation
-
Knox GW, Woodard D, Chelen W, Ferguson R, Johnson L. Phenytoin for motion sickness: clinical evaluation. Laryngoscope 1994; 104: 935-9.
-
(1994)
Laryngoscope
, vol.104
, pp. 935-939
-
-
Knox, G.W.1
Woodard, D.2
Chelen, W.3
Ferguson, R.4
Johnson, L.5
-
20
-
-
0038119445
-
Treatment of downbeat nystagmus with 3,4-diaminopyridine: A placebo-controlled study
-
Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 2003; 61: 165-70.
-
(2003)
Neurology
, vol.61
, pp. 165-170
-
-
Strupp, M.1
Schuler, O.2
Krafczyk, S.3
Jahn, K.4
Schautzer, F.5
Buttner, U.6
-
22
-
-
0023102805
-
Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration
-
Kohl R.L. Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration. Aviat Space Environ Med 1987; 58: 125-31.
-
(1987)
Aviat Space Environ Med
, vol.58
, pp. 125-131
-
-
Kohl, R.L.1
-
23
-
-
0032962585
-
Domperidone: A peripherally acting dopamine2-receptor antagonist
-
Barone JA, Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 1999; 33: 429-40.
-
(1999)
Ann Pharmacother
, vol.33
, pp. 429-440
-
-
Barone, J.A.1
-
25
-
-
0024562738
-
The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties
-
Stott JR, Barnes GR, Wright RJ, Ruddock CJ. The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties. Br J Clin Pharmacol 1989; 27: 147-57.
-
(1989)
Br J Clin Pharmacol
, vol.27
, pp. 147-157
-
-
Stott, J.R.1
Barnes, G.R.2
Wright, R.J.3
Ruddock, C.J.4
-
26
-
-
0018662622
-
Autoimmune sensorineural hearing loss
-
Mc Cabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979; 88: 585-9.
-
(1979)
Ann Otol Rhinol Laryngol
, vol.88
, pp. 585-589
-
-
Mc Cabe, B.F.1
-
27
-
-
0030816548
-
Autoinmmune inner ear disease - A real entity?
-
Barna BP, Hughes GB. Autoinmmune inner ear disease-a real entity? Clin Lab Med 1997; 17: 581-94.
-
(1997)
Clin Lab Med
, vol.17
, pp. 581-594
-
-
Barna, B.P.1
Hughes, G.B.2
-
28
-
-
0033166622
-
Lesion-induced plasticity in rat vestibular nucleus neurones dependent on glucocorticoid receptor activation
-
Cameron SA, Dutia MB. Lesion-induced plasticity in rat vestibular nucleus neurones dependent on glucocorticoid receptor activation. J Physiol 1999; 518: 151-8.
-
(1999)
J Physiol
, vol.518
, pp. 151-158
-
-
Cameron, S.A.1
Dutia, M.B.2
-
29
-
-
0028340835
-
Can vestibular compensation be enhanced by drug treatment? A review of recent evidence
-
Smith PF, Darlington CL. Can vestibular compensation be enhanced by drug treatment? A review of recent evidence. J Vestib Res 1994; 4: 169-79.
-
(1994)
J Vestib Res
, vol.4
, pp. 169-179
-
-
Smith, P.F.1
Darlington, C.L.2
-
30
-
-
0027587744
-
Vestibular compensation is affected by treatment with dopamine active agents
-
Petrosini L, Dell'Anna ME. Vestibular compensation is affected by treatment with dopamine active agents. Arch Ital Biol 1993; 131: 159-71.
-
(1993)
Arch Ital Biol
, vol.131
, pp. 159-171
-
-
Petrosini, L.1
Dell'Anna, M.E.2
-
31
-
-
0023693269
-
Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients
-
Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23: 94-7.
-
(1988)
Ann Neurol
, vol.23
, pp. 94-97
-
-
Crisostomo, E.A.1
Duncan, P.W.2
Propst, M.3
Dawson, D.V.4
Davis, J.N.5
-
32
-
-
0034353583
-
Medical treatment in Meniere's disease: Avoiding vestibular neurectomy and facilitating postoperative compensation
-
Colletti V. Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol Suppl 2000; 544: 27-33.
-
(2000)
Acta Otolaryngol Suppl
, vol.544
, pp. 27-33
-
-
Colletti, V.1
-
33
-
-
0017550221
-
Old and new in Meniere disease
-
Torok N. Old and new in Meniere disease. Laryngoscope 1977; 87: 1870-7.
-
(1977)
Laryngoscope
, vol.87
, pp. 1870-1877
-
-
Torok, N.1
-
34
-
-
0025920886
-
The treatment of Meniere's disease: Torok revisited
-
Ruckenstein MJ, Rutka JA, Hawke M. The treatment of Meniere's disease: Torok revisited. Laryngoscope 1991; 101: 211-8.
-
(1991)
Laryngoscope
, vol.101
, pp. 211-218
-
-
Ruckenstein, M.J.1
Rutka, J.A.2
Hawke, M.3
-
35
-
-
0025924551
-
Histamine in the treatment of vertigo
-
Fischer AJ. Histamine in the treatment of vertigo. Acta Otolaryngol Suppl 1991; 479: 24-8.
-
(1991)
Acta Otolaryngol Suppl
, vol.479
, pp. 24-28
-
-
Fischer, A.J.1
-
36
-
-
0030846758
-
Dose-dependent effect of betahistine on the vestibulo-ocular reflex: A double-blind, placebo controlled study in patients with paroxysmal vertigo
-
Kingma H, Bonink M, Meulenbroeks A, Konijnenberg H. Dose-dependent effect of betahistine on the vestibulo-ocular reflex: a double-blind, placebo controlled study in patients with paroxysmal vertigo. Acta Otolaryngol 1997; 117: 641-6.
-
(1997)
Acta Otolaryngol
, vol.117
, pp. 641-646
-
-
Kingma, H.1
Bonink, M.2
Meulenbroeks, A.3
Konijnenberg, H.4
-
37
-
-
0031856618
-
Effects of betahistine on vestibular receptors of the frog
-
Botta L, Mira E, Valli S, Perin P, Zucca G, Valli P. Effects of betahistine on vestibular receptors of the frog. Acta Otolaryngol 1998; 118: 519-23.
-
(1998)
Acta Otolaryngol
, vol.118
, pp. 519-523
-
-
Botta, L.1
Mira, E.2
Valli, S.3
Perin, P.4
Zucca, G.5
Valli, P.6
-
39
-
-
0035211581
-
Histamine and betahistine in the treatment of vertigo: Elucidation of mechanisms of action
-
Lacour M, Sterkers O. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action. CNS Drugs 2001; 15: 853-70.
-
(2001)
CNS Drugs
, vol.15
, pp. 853-870
-
-
Lacour, M.1
Sterkers, O.2
-
40
-
-
0031756716
-
Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders
-
Cesarani A, Meloni F, Alpini D, Barozzi S, Verderio L, Boscani PF. Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders. Adv Ther 1998; 15: 291-304.
-
(1998)
Adv Ther
, vol.15
, pp. 291-304
-
-
Cesarani, A.1
Meloni, F.2
Alpini, D.3
Barozzi, S.4
Verderio, L.5
Boscani, P.F.6
-
41
-
-
0031850037
-
Homeopathic vs conventional treatment of vertigo: A randomized double-blind controlled clinical study
-
Weiser M, Strosser W, Klein P. Homeopathic vs conventional treatment of vertigo: a randomized double-blind controlled clinical study. Arch Otolaryngol Head Neck Surg 1998; 124: 879-85.
-
(1998)
Arch Otolaryngol Head Neck Surg
, vol.124
, pp. 879-885
-
-
Weiser, M.1
Strosser, W.2
Klein, P.3
-
42
-
-
0033094743
-
The effectiveness of piracetam in vertigo
-
Oosterveld WJ. The effectiveness of piracetam in vertigo. Pharmacopsychiatry 1999; 32 (Suppl 1): 54-60.
-
(1999)
Pharmacopsychiatry
, vol.32
, Issue.SUPPL. 1
, pp. 54-60
-
-
Oosterveld, W.J.1
-
43
-
-
0024319071
-
Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes
-
Ordosgoitia H, Castro C, Carbayeda M, Labella T. Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes. An Otorrinolaringol Ibero Am 1989; 16: 271-9.
-
(1989)
An Otorrinolaringol Ibero Am
, vol.16
, pp. 271-279
-
-
Ordosgoitia, H.1
Castro, C.2
Carbayeda, M.3
Labella, T.4
-
44
-
-
0032601606
-
The effect of pharmacological treatment in the compensation of vertigo
-
Pons-Rocher F. The effect of pharmacological treatment in the compensation of vertigo. An Otorrinolaringol Ibero Am 1999; 26: 271-91.
-
(1999)
An Otorrinolaringol Ibero Am
, vol.26
, pp. 271-291
-
-
Pons-Rocher, F.1
-
46
-
-
0036289036
-
Clonazepam in the pharmacological treatment of vertigo and tinnitus
-
Gananca MM, Caovilla HH, Gananca FF, Gananca CF, Munhoz MS, da Silva ML, et al. Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 2002; 8: 50-3.
-
(2002)
Int Tinnitus J
, vol.8
, pp. 50-53
-
-
Gananca, M.M.1
Caovilla, H.H.2
Gananca, F.F.3
Gananca, C.F.4
Munhoz, M.S.5
Da Silva, M.L.6
-
47
-
-
0018902624
-
Physical therapy for benign paroxysmal positional vertigo
-
Brandt T, Daroff RB. Physical therapy for benign paroxysmal positional vertigo. Arch Otolaryngol 1980; 106: 484-5.
-
(1980)
Arch Otolaryngol
, vol.106
, pp. 484-485
-
-
Brandt, T.1
Daroff, R.B.2
-
48
-
-
0031009672
-
A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus
-
Averbuch-Heller L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997; 41: 818-25.
-
(1997)
Ann Neurol
, vol.41
, pp. 818-825
-
-
Averbuch-Heller, L.1
Tusa, R.J.2
Fuhry, L.3
Rottach, K.G.4
Ganser, G.L.5
Heide, W.6
-
50
-
-
0031886138
-
Efficacy of vestibular rehabilitation
-
Cowand JL, Wrisley DM, Walker M, Strasnick B, Jacobson JT. Efficacy of vestibular rehabilitation. Otolaryngol Head Neck Surg 1998; 118: 49-54.
-
(1998)
Otolaryngol Head Neck Surg
, vol.118
, pp. 49-54
-
-
Cowand, J.L.1
Wrisley, D.M.2
Walker, M.3
Strasnick, B.4
Jacobson, J.T.5
-
51
-
-
0037287217
-
Increased independence and decreased vertigo after vestibular rehabilitation
-
Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation. Otolaryngol Head Neck Surg 2003; 128: 60-70
-
(2003)
Otolaryngol Head Neck Surg
, vol.128
, pp. 60-70
-
-
Cohen, H.S.1
Kimball, K.T.2
-
52
-
-
0026770472
-
Extrapyramidal side effects of antiemetics presenting as psychiatric illness
-
Rodgers C. Extrapyramidal side effects of antiemetics presenting as psychiatric illness. Gen Hosp Psychiatry 1992; 14: 192-5.
-
(1992)
Gen Hosp Psychiatry
, vol.14
, pp. 192-195
-
-
Rodgers, C.1
-
53
-
-
0029054518
-
Ondansetron for intractable vertigo complicating acute brainstem disorders
-
Rice GP, Ebers GC. Ondansetron for intractable vertigo complicating acute brainstem disorders. Lancet 1995; 345: 1182-3.
-
(1995)
Lancet
, vol.345
, pp. 1182-1183
-
-
Rice, G.P.1
Ebers, G.C.2
|